| Publication Number | Title | Priority Date |
|---|---|---|
| US-2021251982-A1 | Methods for treating neurological symptoms associated with lysosomal storage diseases | 2020-02-03 |
| TW-202132298-A | Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use | 2019-11-25 |
| WO-2020163337-A1 | Treatment of ciliopathies using inhibitors of glucosylceramide synthase (gcs) | 2019-02-04 |
| TW-202045167-A | Methods for treating symptoms and disorders associated with lysosomal storage diseases | 2019-02-04 |
| TW-202045168-A | Methods for treating symptoms and disorders associated with lysosomal storage diseases | 2019-02-04 |
| AU-2020218185-A1 | Treatment of ciliopathies using inhibitors of glucosylceramide synthase (GCS) | 2019-02-04 |
| CA-3128039-A1 | Methods for treating symptoms and disorders associated with lysosomal storage diseases | 2019-02-04 |
| CA-3128041-A1 | Methods for treating symptoms and disorders associated with lysosomal storage diseases | 2019-02-04 |
| CA-3128043-A1 | Treatment of ciliopathies using inhibitors of glucosylceramide synthase (gcs) | 2019-02-04 |
| IL-285187-D0 | Methods of treating symptoms and disorders associated with lysosomal storage diseases | 2019-02-04 |
